(Q48583642)

13 February 2018

editorial

0 references

title

PDE inhibition and cognition enhancement (English)

1 reference

13 February 2018

author

Frank S. Menniti

series ordinal

2

1 reference

13 February 2018

author name string

Arjan Blokland

series ordinal

1

1 reference

13 February 2018

Jos Prickaerts

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 April 2012

1 reference

13 February 2018

Expert Opinion on Therapeutic Patents

published in

1 reference

13 February 2018

volume

22

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

349-354

1 reference

13 February 2018

Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Use of behavioural and long-term potentiation models in the development of memory-improving drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

LTP forms 1, 2 and 3: different mechanisms for the "long" in long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Phosphodiesterase inhibitors as potential cognition enhancing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.674514

10.1517/13543776.2012.674514

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

release_2xtdlq2y3rd4rcieefooxouqne

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2xtdlq2y3rd4rcieefooxouqne

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 February 2018